Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AQX-1125 crossover allergen challenge study in mild to moderate atopic asthma
2011-003012-23Phase 2Completed
- Sponsor
- Aquinox Pharmaceuticals
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AQX-1125 in asthma, sponsored by Aquinox Pharmaceuticals. Started Aug 2011; status: completed.
02
Drugs
AQX-1125
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-003012-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003012-23.